
States Confront Oversight of Medical Chatbots While FDA Stands Down: Implications From Pennsylvania’s Character.AI Lawsuit
<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxORGpMOFl3NnlHZ21LRU5uNUxkNm9LTWJGZk1lQzFuanNiTTVuYkZvRlE1dkdhMlg0VFRKZTN3RDNvanMwcUFtME9OWV8wTUJwOWxxdTlKZVpYeTNhVWhvSG8tRWhUNmJabG9YWHctb0lZanpxZ1pxb0JKcXBkSFNEaHVmZlNSbWppRkpjc2xSR3FPampscnJBbUpYWEg0NzdnOS1CTnhKSHBfRW5WM2Q0RlRZNDA2WnUxN3ZHYUtEVUp2SWV0UnRrZmdJNEtFV3J6S21UbzB4b0tfZk05LXVTVVI3SEc4TE84Mlk1REl5SHlBbU1tMDRfRW1VbmEwM3ItSGNZ?oc=5" target="_blank">States Confront Oversight of Medical Chatbots While FDA Stands Down: Implications From Pennsylvania’s Character.AI Lawsuit</a>&nbsp;&nbsp;<font color="#6f6f6f">Akin Gump Strauss Hauer & Feld LLP</font>
